DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Mizuho's"


25 mentions found


☆ CNBC Daily Open: Goodbye for now, default fears
  + stars: | 2023-05-18 | by ( Yeo Boon Ping | ) www.cnbc.com   time to read: +2 min
Progress on U.S. debt ceiling talks and a sign of health at one regional bank gave markets the confidence to rally Wednesday. This report is from today's CNBC Daily Open, our new, international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. PacWest, another regional bank, surged 21.7%, while the broader SPDR S&P Regional Banking ETF (KRE) rose 7.4%. Subscribe here to get this report sent directly to your inbox each morning before markets open.
☆ Blocking the Horizon-Amgen deal will be worse for pharma than for biotech, says Mizuho's Jared Holz
  + stars: | 2023-05-18 | by ( ) www.cnbc.com   time to read: 1 min
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailBlocking the Horizon-Amgen deal will be worse for pharma than for biotech, says Mizuho's Jared HolzJared Holz, Mizuho healthcare sector strategist, joins 'Fast Money' to discuss merger and acquisition crackdowns in the biotech space, government regulation in the space, and more.
☆ The bears are mathematically and intellectually wrong about SoFi's loans, says Mizuho's Dan Dolev
  + stars: | 2023-05-16 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailThe bears are mathematically and intellectually wrong about SoFi's loans, says Mizuho's Dan DolevDan Dolev, managing director at Mizuho Securities, joins 'The Exchange' to discuss skepticism surrounding SoFi's loan performance, the bullish case for SoFi, and caution around prospects for fintech.
☆ Intel remains a 'show me' story, says Mizuho's Vijay Rakesh
  + stars: | 2023-04-28 | by ( ) www.cnbc.com   time to read: 1 min
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailIntel remains a 'show me' story, says Mizuho's Vijay RakeshVijay Rakesh, Mizuho, joins 'Closing Bell' to discuss Intel after the company reported earnings after the bell Thursday.
☆ Weight loss drug market is just beginning to take off, says Mizuho's Jared Holz
  + stars: | 2023-04-28 | by ( ) www.cnbc.com   time to read: 1 min
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWeight loss drug market is just beginning to take off, says Mizuho's Jared HolzJared Holz, Mizuho healthcare equity strategist, joins 'The Exchange' to discuss new weight loss drugs coming to market, forecasts for market expansion in weight loss drugs, and key players in the weight loss drug sector.
☆ Watch CNBC's full interview with Mizuho's Vijay Rakesh and Gerber Kawasaki's Ross Gerber
  + stars: | 2023-04-20 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWatch CNBC's full interview with Mizuho's Vijay Rakesh and Gerber Kawasaki's Ross GerberVijay Rakesh, managing director and senior semiconductor analyst at Mizuho, and Ross Gerber, president and CEO of Gerber Kawasaki, join 'Squawk on the Street' to discuss Tesla's margin picture, Rakesh's take on the company's quarterly earnings results, and more.
☆ Mizuho's EV warning: GM's transition to EVs will face profitability hurdle
  + stars: | 2023-04-14 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailMizuho's EV warning: GM's transition to EVs will face profitability hurdleHosted by Brian Sullivan, “Last Call” is a fast-paced, entertaining business show that explores the intersection of money, culture and policy. Tune in Monday through Friday at 7 p.m. ET on CNBC. Mark Fields, former Ford Motor Co. CEO, joins the show to discuss the White House's push for EV vehicles.
☆ Drugs for obesity are a massive market, says Mizuho's Jared Holz
  + stars: | 2023-03-29 | by ( Melissa Lee | ) www.cnbc.com   time to read: 1 min
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailDrugs for obesity are a massive market, says Mizuho's Jared HolzJared Holz, Mizuho, joins 'Fast Money' to discuss obesity drugs with CNBC's Tyler Mathisen and the Fast Money traders.
☆ Micron's worst quarter is behind them, says Mizuho's Vijay Rakesh
  + stars: | 2023-03-29 | by ( ) www.cnbc.com   time to read: 1 min
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailMicron's worst quarter is behind them, says Mizuho's Vijay RakeshVijay Rakesh, managing director and senior semiconductor analyst at Mizuho, joins 'Squawk on the Street' to discuss his thoughts on Micron after the company missed fiscal second-quarter expectations.
☆ Block was down today because of what wasn't in Hindenburg's report, says Mizuho's Dolev
  + stars: | 2023-03-23 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailBlock was down today because of what wasn't in Hindenburg's report, says Mizuho's DolevMizuho's Dan Dolev joins the 'CNBC Special: Taking stock' to discuss his bullish take on Block.
☆ Wall Street says Meta job cuts reiterate focus on efficiency, offer 'rare EPS upside story'
  + stars: | 2023-03-15 | by ( Samantha Subin | ) www.cnbc.com   time to read: +3 min
The latest round of job cuts at Meta Platforms is boosting Wall Street's confidence in the upside potential for earnings in the months and year ahead. It's another round of eliminations after Meta's announcement in November that it would be laying off 13% of its workforce. Despite the blow to workers, Wall Street views the latest round of layoffs as a sign that Meta Platforms is following through on these efficiency plans. Post called the company in a Tuesday note a "rare EPS upside story," saying that the cuts should set Meta up to generate higher profitability once the economy reaccelerates. Although Wall Street broadly praised the latest efficiency move from Meta, some analysts say there's more work to do.
☆ Salesforce follows Microsoft in launching A.I. tools for salespeople with help from OpenAI
  + stars: | 2023-03-07 | by ( Jordan Novet | ) www.cnbc.com   time to read: +4 min
The company said Tuesday that it will release software incorporating artificial intelligence to help salespeople, customer service agents and marketers do their jobs. Salesforce is calling the offering Einstein GPT, drawing on OpenAI's technology that's taken the tech industry by storm since the Microsoft-backed startup opened ChatGPT to the public in November. These AI models sometimes display incorrect information, prompting companies that sell to big businesses and governments to proceed carefully. Like Salesforce, Microsoft is trying to keep the spread of incorrect information to a minimum as it brings AI features to its competing Dynamics 365 software. Salesforce is also touting a new ChatGPT app for Slack that can display information derived from Salesforce.
☆ Salesforce faces an underappreciated risk: Platform customers jumping ship like Veeva
  + stars: | 2023-03-04 | by ( Jordan Novet | ) www.cnbc.com   time to read: +4 min
Veeva built its core software on top of Salesforce's app-development platform, but that will be coming to an end in 2025. Peter Gassner, Veeva's founder and CEO, ran the Salesforce platform before starting Veeva in 2007. "Peter has been an outstanding CEO," Benioff was quoted as saying in 2017, as the two companies deepened their partnership. The agreement between the companies holds that Veeva is on the hook to pay Salesforce as Veeva customers use Salesforce's platform — and costs have risen as more people have come to rely on Veeva. But it has grown into a profitable publicly traded software company with $2 billion in annual revenue and a $28 billion market capitalization.
☆ Nobody was expecting a 27% margin guide from Salesforce, says Mizuho's Greg Moskowitz
  + stars: | 2023-03-02 | by ( ) www.cnbc.com   time to read: 1 min
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailNobody was expecting a 27% margin guide from Salesforce, says Mizuho's Greg MoskowitzMizuho's Greg Moskowitz and CNBC's Steve Kovach join 'Power Lunch' to discuss Salesforce's earnings results and whether the company's successful quarter will keep activist investors at bay.
☆ Watch CNBC's full interview with Mizuho's Greg Moskowitz and CNBC's Steve Kovach
  + stars: | 2023-03-02 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWatch CNBC's full interview with Mizuho's Greg Moskowitz and CNBC's Steve KovachMizuho's Greg Moskowitz and CNBC's Steve Kovach join 'Power Lunch' to discuss Salesforce's earnings results and whether the company's successful quarter will keep activist investors at bay.
☆ I don't see great things for Coinbase in 2023, says Mizuho's Dan Dolev
  + stars: | 2023-02-21 | by ( ) www.cnbc.com   time to read: 1 min
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailI don't see great things for Coinbase in 2023, says Mizuho's Dan DolevDan Dolev of Mizuho Securities joins 'Closing Bell: Overtime' to discuss Coinbase's earnings announcement and what he thinks about the company's future.
☆ Mitsubishi UFJ, Mizuho report strong Q3 results on solid loan demand
  + stars: | 2023-02-02 | by ( ) www.reuters.com   time to read: +1 min
TOKYO, Feb 2 (Reuters) - Mitsubishi UFJ Financial Group Inc (8306.T) and Mizuho Financial Group (8411.T) on Thursday reported strong third-quarter profits in their core businesses thanks to an economic rebound in Japan and solid loan demand abroad. Including the expected accounting gain, Mitsubishi UFJ's nine-month net profit totalled 1.14 trillion yen ($8.86 billion), already ahead of its full-year profit forecast of 1 trillion yen. Mizuho's third-quarter net profit more than doubled to 209.3 billion yen compared to the same period last year, when results at the country's No. 3 lender were weighed down by loan loss provisions for KKR & Co's (KKR.N) auto parts supplier Marelli Holdings Co.Japan's second-largest bank, Sumitomo Mitsui Financial Group Inc (8316.T), on Monday reported a 42.6% jump in third-quarter net profit. ($1 = 128.6100 yen)Reporting by Makiko Yamazaki; Editing by Christian Schmollinger and Jamie FreedOur Standards: The Thomson Reuters Trust Principles.
☆ Meta's short video Reels may finally be ready to challenge TikTok, analysts say
  + stars: | 2023-02-02 | by ( Samantha Subin | ) www.cnbc.com   time to read: +4 min
Improving Reels engagement is boosting analysts' confidence in the short-form video platform's ability to compete with TikTok. META 1D mountain Meta Platforms shares surged more than 28% Thursday, on pace for their best day since 2013. Looking ahead, some analysts believe that Reels plays a dominant role in improving Facebook's efficiency. Easing TikTok tensions As for TikTok, some analysts say Reels is in position to overtake the short-form video leader that finds itself under increasing pressure as calls for a nationwide bans grow. JPMorgan analyst Doug Anmuth views improving Reels engagement trends and artificial intelligence investments as a way to temper threats from TikTok.
☆ Accelerated inventory cuts in semis helping stabilize stocks faster, says Mizuho's Vijay Rakesh
  + stars: | 2023-01-30 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailAccelerated inventory cuts in semis helping stabilize stocks faster, says Mizuho's Vijay RakeshVijay Rakesh, managing director and senior semiconductor analyst at Mizuho, joins 'The Exchange' to discuss chip stocks inventory correction, semis with auto exposure, and investment opportunities in the second half of the year.
☆ Tesla will see a drag on earnings today, says Mizuho's Vijay Rakesh
  + stars: | 2023-01-25 | by ( ) www.cnbc.com   time to read: 1 min
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailTesla will see a drag on earnings today, says Mizuho's Vijay RakeshMizuho's Vijay Rakesh and Tim Higgins, Wall Street Journal tech reporter, join 'The Exchange' to discuss Tesla shares moving higher ahead of its earnings report today.
☆ Mizuho's Dan Dolev breaks down his underperform rating on Coinbase
  + stars: | 2023-01-24 | by ( ) www.cnbc.com   time to read: 1 min
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailMizuho's Dan Dolev breaks down his underperform rating on CoinbaseDan Dolev, Mizuho Managing Director, joins 'TechCheck' to discuss crypto, Tesla, and the bear case for coinbase.
☆ ServiceNow remains customer favorite for IT spending, says Mizuho's Gregg Moskowitz
  + stars: | 2023-01-20 | by ( ) www.cnbc.com   time to read: 1 min
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailServiceNow remains customer favorite for IT spending, says Mizuho's Gregg MoskowitzMizuho's Gregg Moskowitz joins 'Closing Bell Overtime' to discuss distinguishing priorities for software vendors, challenged IT budges in 2023, and long-term software opportunities.
☆ Eli Lilly has spent years and billions of dollars in search of an effective Alzheimer's drug. But success is not all or nothing for the stock
  + stars: | 2023-01-09 | by ( Kevin Stankiewicz | ) www.cnbc.com   time to read: +22 min
Eli Lilly (LLY) has spent decades researching Alzheimer's disease without successfully bringing to market a treatment that slows the memory-destroying condition. For Eli Lilly as a company, an Alzheimer's drug is an important pursuit. Lilly's Alzheimer's history Eli Lilly's "first real foray" into Alzheimer's came in the 1990s, according to Dr. John Sims, Eli Lilly's head of medical development for donanemab. Financial implications for Lilly LLY mountain 2021-10-08 The Club started a new position in Eli Lilly (LLY) in October 2021. The Eli Lilly logo is shown on one of the company's offices in San Diego, California, September 17, 2020.
☆ Robinhood's appeal to younger investors presents room for additional growth, says Mizuho's Dolev
  + stars: | 2022-12-12 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailRobinhood's appeal to younger investors presents room for additional growth, says Mizuho's DolevMizuho's Dan Dolev joins 'TechCheck' to discuss the reasons behind his bullish call on Robinhood due to new product releases, its younger population of users and profitability numbers.
☆ Watch CNBC's full interview with Mizuho's Salim Syed
  + stars: | 2022-12-12 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWatch CNBC's full interview with Mizuho's Salim SyedSalim Syed, Mizuho senior biotech analyst, joins 'Squawk on the Street' to discuss biotech M&A in general, the Amgen Horizon Therapeutics acquisition, and the balance sheet concerns associated with Amgen.
<< prev 3 next >>
Total: 25